Evergreen Theragnostics

Evergreen Theragnostics is a specialized company focused on the manufacturing, development, and distribution of therapeutic and diagnostic radiopharmaceuticals. The company operates in the biopharmaceutical sector, catering to clients involved in clinical trials and commercial radiopharmaceutical applications. Evergreen Theragnostics serves a diverse range of clients, including pharmaceutical companies, research institutions, and healthcare providers. The business model revolves around providing a broad range of services for centrally distributed radiopharmaceuticals, from early-phase clinical trials (Phase 0) through to full commercialization. Revenue is generated through service contracts, manufacturing agreements, and distribution deals. The company has established itself as a leader in the North American market, known for its unrivaled expertise and state-of-the-art production facilities. Evergreen Theragnostics recently completed a $19 million Series A capital raise, which will support the expansion of its manufacturing capabilities and further development of its service offerings.

Keywords: radiopharmaceuticals, manufacturing, development, distribution, clinical trials, commercialization, biopharmaceutical, healthcare, North America, expertise.